
This fund's primary objective is to achieve the highest possible long-term capital appreciation. The investment management team utilizes a fundamental research methodology to build a diverse portfolio. This portfolio comprises growth companies from both domestic and international markets, spanning a wide spectrum of market capitalizations. Their strategy involves identifying companies that they believe exhibit strong competitive advantages, are experiencing an accelerating profit growth cycle, and are currently valued below their estimated private market worth.
Is ARTRX's expense ratio expensive, average, or a steal for its category?
Pro reveals the verdict on a 5-tier spectrum calibrated against ICI 2025 industry averages, with strategy-aware bands so the comparison is meaningful.
No recent news available.